Like the overall market, the second quarter for the Life Science Instrument industry shows both current economic strength but also uncertainty for the future.
IBO looks at the role that foreign and domestic lab instrument brands play in China
Company annual revenues more than double
NHS launches national genomic test program
Pharma and CROs to drive MS-IMS growth
Decision affects Bio-Rad patents
Oil companies increase investments in natural gas
PhRMA members support biotech startups through corporate VC funds
GCC countries increase funding in infrastructure, but need to improve research ecosystems
New OECD report examines how public research policies are governed
Pay Invoice
Latest Blogs
-
SDi Forecasts Growth in Demand for Analytical Instruments 2024–2029
May 29, 2025 1:38 pm
-
NIH Disruptions and Lab Tool Companies: Stocks React
April 30, 2025 1:17 pm
-
Federal R&D Obligations for the NIH Decline in FY24
March 27, 2025 3:02 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
